Astrocyte Pharmaceuticals Receives NIH Award to Evaluate AST-004 in Substance Use Disorders
GROTON, Conn., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc., a clinical-stage biotechnology company developing first-in-class cerebroprotective therapies, the Oklahoma Medical Research Foundation (OMRF), and The University of Texas at …